経カテーテル大動脈弁置換術市場：手技タイプ別、デバイスタイプ別、エンドユーザー別、地域別

経カテーテル大動脈弁置換術の世界市場は、2024年には67億1,000万米ドルと推定され、2031年には108億米ドルに達すると予測され、2024年から2031年までのCAGRは7％を示しています。

図.経カテーテル大動脈弁置換術市場 地域別シェア（%）2024年

経カテーテル大動脈弁置換術の世界市場は、高齢者人口の増加と世界の大動脈弁狭窄症の有病率の増加を背景に、過去10年間で急速に成長しています。TAVR手技は、開心術のリスクが高い重度の大動脈弁狭窄症患者に低侵襲の治療選択肢を提供します。この手技では、折りたたみ可能な人工心臓弁をカテーテルを通して体内に挿入し、病変のある本来の大動脈弁の内側に設置します。この方法は、大出血、感染症、長い入院期間といった開心術に伴うリスクを軽減します。TAVRの安全性、有効性、長寿命がより多くの臨床的証拠によって証明されるにつれ、患者の適格基準は拡大し、北米などの主要地域でより広範な市場導入が推進されています。特にバルブデリバリーシステムに関する広範な技術進歩や新製品の承認も、TAVRの世界の普及を後押ししています。

市場力学：

経カテーテル大動脈弁置換術の世界市場は、主に大動脈弁狭窄症に罹患しやすい高齢者人口の急増によって牽引されています。世界の平均寿命の伸びと人口動態の高齢化により、心臓弁置換術を必要とする患者数は大幅に増加しています。2024年10月、WHOの推計によると、60歳以上の世界人口は2015年から2050年の間に12％から22％に倍増すると予測されています。心血管疾患の負担の増大と低侵襲手術に対する意識の高まりが、経カテーテル的大動脈弁置換術の採用をさらに後押ししています。経カテーテル的アプローチは、回復時間の短縮、入院期間の短縮、合併症リスクの低減、特にハイリスク患者への対応が可能であるため、開心術よりも好まれています。しかし、人口の大多数が高度な心臓医療を受けられない新興国では、経カテーテル的大動脈弁置換術の市場開発の可能性はまだ未開発です。

本調査の主な特徴

この調査レポートは、経カテーテル大動脈弁置換術の世界市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模（10億米ドル）および複合年間成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

経カテーテル大動脈弁置換術の世界市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

本調査の対象となる主要企業には、Edwards Lifesciences Corp.、Medtronic Plc.、Abbott Laboratories.、Boston Scientific Corp.、MicroPort Scientific Corp.、JenaValve Technology GmbH.、Cardiovascular Systems, Inc.、Symetis SA.、Lepu Medical Technology Co.Ltd.、Terumo Corporation.、St. Jude Medical（現在はAbbott傘下）、AtriCure, Inc.、Vascular Solutions, Inc.、Biotronik SE &Co.KG.、Cook Medical.があります。

本レポートの洞察により、マーケティング担当者や各企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、十分な情報に基づいた意思決定を行うことができます。

経カテーテル大動脈弁置換術の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界の経カテーテル大動脈弁置換術市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の経カテーテル大動脈弁置換術市場、手術タイプ別、2019年-2031年

• 経大腿
• 経頂
• その他のアプローチ

第5章 世界の経カテーテル大動脈弁置換術市場、デバイスタイプ別、2019年-2031年

• バルーン拡張弁
• 自己拡張バルブ

第6章 世界の経カテーテル大動脈弁置換術市場、エンドユーザー別、2019年-2031年

• 病院
• 外来手術センター
• 独立した心臓カテーテル検査室
• その他

第7章 世界の経カテーテル大動脈弁置換術市場、地域別、2019年-2031年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第8章 競合情勢

• Edwards Lifesciences Corp.
• Medtronic Plc.
• Abbott Laboratories.
• Boston Scientific Corp.
• MicroPort Scientific Corp.
• JenaValve Technology GmbH.
• Cardiovascular Systems, Inc.
• Symetis SA.
• Lepu Medical Technology Co., Ltd.
• Terumo Corporation.
• Jude Medical（now part of Abbott）.
• AtriCure, Inc.
• Vascular Solutions, Inc.
• Biotronik SE & Co. KG.
• Cook Medical

第9章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫した機会マップ

第10章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

The global transcatheter aortic valve replacement market is estimated to be valued at USD 6.71 Bn in 2024 and is expected to reach USD 10.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.

Figure. Transcatheter Aortic Valve Replacement Market Share (%), By Region 2024

The global transcatheter aortic valve replacement market has been growing rapidly over the past decade backed by the rising geriatric population and increasing prevalence of aortic stenosis globally. TAVR procedures offer a minimally invasive treatment option for severe aortic stenosis patients who are at high risk for open-heart surgeries. The technique involves threading a collapsible prosthetic heart valve through a catheter into the body and placing it inside the diseased native aortic valve. This method reduces risks associated with open-heart surgeries such as severe bleeding, infections, and long hospital recovery times. As more clinical evidence demonstrates the safety, efficacy, and longevity of TAVR patient eligibility criteria have expanded, driving wider market adoption in key regions such as North America. Widespread technological advancements especially around valve delivery systems and new product approvals too have boosted the uptake of TAVR globally.

Market Dynamics:

The global transcatheter aortic valve replacement market is primarily driven by the rapidly growing geriatric population base that is more susceptible to aortic stenosis. Rising life expectancy and aging demographics worldwide have significantly upscaled the patient pool requiring heart valve replacements. In October 2024, as per the WHO estimates, the global population aged 60 years and over is projected to double from 12% to 22% between 2015 and 2050. Growing burden of cardiovascular diseases and increasing awareness about minimally invasive procedures have further propelled the adoption of transcatheter aortic valve replacement. Transcatheter approaches are preferred over open-heart surgeries since they offer shortened recovery times, reduced hospital stays, and lower complication risks, especially for high-risk patients. However, the market potential of transcatheter aortic valve replacement is still untapped in developing nations where a majority population lacks access to advanced cardiac care.

Key Features of the Study:

This report provides in-depth analysis of the global transcatheter aortic valve replacement market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global transcatheter aortic valve replacement market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Edwards Lifesciences Corp., Medtronic Plc., Abbott Laboratories., Boston Scientific Corp., MicroPort Scientific Corp., JenaValve Technology GmbH., Cardiovascular Systems, Inc., Symetis SA., Lepu Medical Technology Co., Ltd., Terumo Corporation., St. Jude Medical (now part of Abbott)., AtriCure, Inc., Vascular Solutions, Inc., Biotronik SE & Co. KG., and Cook Medical

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global transcatheter aortic valve replacement market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter aortic valve replacement market

Market Segmentation

• By Procedure Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Transfemoral
  • Transapical
  • Other Approaches
• By Device Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Balloon-Expandable Valves
  • Self-Expanding Valves
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Ambulatory Surgical Centers
  • Independent Cardiac Catheterization Labs
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Edwards Lifesciences Corp.
  • Medtronic Plc.
  • Abbott Laboratories.
  • Boston Scientific Corp.
  • MicroPort Scientific Corp.
  • JenaValve Technology GmbH.
  • Cardiovascular Systems, Inc.
  • Symetis SA.
  • Lepu Medical Technology Co., Ltd.
  • Terumo Corporation.
  • Jude Medical (now part of Abbott).
  • AtriCure, Inc.
  • Vascular Solutions, Inc.
  • Biotronik SE & Co. KG.
  • Cook Medical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Transcatheter Aortic Valve Replacement Market, By Procedure Type
  • Global Transcatheter Aortic Valve Replacement Market, By Device Type
  • Global Transcatheter Aortic Valve Replacement Market, By End User
  • Global Transcatheter Aortic Valve Replacement Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Transcatheter Aortic Valve Replacement Market, By Procedure Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Transfemoral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Transapical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Other Approaches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Transcatheter Aortic Valve Replacement Market, By Device Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Balloon-Expandable Valves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Self-Expanding Valves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Transcatheter Aortic Valve Replacement Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Independent Cardiac Catheterization Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Transcatheter Aortic Valve Replacement Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Procedure Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Device Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Edwards Lifesciences Corp.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic Plc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corp.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• MicroPort Scientific Corp.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• JenaValve Technology GmbH.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardiovascular Systems, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Symetis SA.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lepu Medical Technology Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Terumo Corporation.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jude Medical (now part of Abbott).
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AtriCure, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vascular Solutions, Inc.
• Biotronik SE & Co. KG.
• Cook Medical

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us